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Introduction
Primitive neuroectodermal tumours (PNETs) are rare tumours 
originating from cells of primitive neural crest. The majority of 
PNETs arise in the central nervous system (CNS). PNETs seen 
outside the CNS are called  periferal primitive neuroectodermal 
tumors (pPNET)s [1-3]. pPNETs are commonly present 
in the thoracopulmonary region, abdomen, pelvis and the 
extremities but infrequently in the head and neck. Orbital 
location is infrequent and seen mostly secondary to metastatic 
spread of PNETs [1-5]. Only eighteen orbital pPNET cases 
have been reported in the literature up to now [5]. In the 
differential diagnosis of  orbital pPNET, other small blue 
round cell tumours like Ewing’s sarcoma, rhabdomyosarcoma, 
lymphoma, neuroblastoma and metastatic retinoblastoma of 
the orbit should be considered (Table I) [4,5]. pPNETs occur 
predominantly in children and young adults and show no 
gender difference [1,6,7]. The treatment for pPNET usually 
involves a combination of surgery and chemotherapy with or 
without radiotherapy [3,6].
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ABSTRACT
Primitive neuroectodermal tumours (PNETs) are a group of 
malignant soft tissue tumours of neuroepithelial origin that 
arise from primitive neural crest cells. Most of the PNETs occur 
in the central nervous system (CNS). If the origin is outside the 
CNS  it is called peripheral primitive neuroectodermal tumour 
(pPNET). Histopathologically, PNETs consist of small round 
cells with a hyperchromatic nuclei, high nuclear-cytoplasmic 
ratio and varying degrees of neural differentiation detectable by 
immunohistochemical or ultrastructural techniques. pPNETs occur 
predominantly in children and young adults and show no gender 
difference. Occurrences of pPNETs in the orbit are  infrequent and 
to the best of our knowledge only eighteen cases have been reported 
in the literature up to now. In this study, we present clinic, radiologic 
and histopathologic features of an orbital mass  in an 8-year-old boy, 
which was diagnosed as  a  primary orbital pPNET confirmed by 
immunohistochemistry.
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ÖZET
Primitif nöroektodermal tümörler (PNET) primitif nöral krest 
hücrelerinden köken alan bir grup malign yumuşak doku 
tümörleridir. Tümör,  santral sinir sistemi ya da beyin dışındaki 
yumuşak dokulardan köken alırsa, periferik primitif nöroektodermal 
tümör (pPNET) adını almaktadır. Histopatolojik olarak PNET 
hiperkromatik nükleuslu, yüksek nükleus/stoplazma oranına 
sahip, immünohistokimyasal ve/veya ultrastrüktürel teknikler 
ile saptanabilen değişik derecelerde nöral diferansiasyona sahip 
küçük yuvarlak hücrelerden oluşmaktadır. pPNET genellikle 
genç erişkin ve çocuklarda ortaya çıkmakta olup cinsiyet ayrımı 
göstermez. Orbital yerleşim nadir izlenmektedir ve şimdiye kadar, 
literatürde yalnızca on sekiz vaka bildirimine ulaşılmaktadır. Biz, 
bu çalışmamızda immunohistokimyasal olarak pPNET tanısı 
onaylanmış 8 yaşında erkek çocuğun gözünde saptanan kitlenin 
klinik, radyolojik ve histopatolojik özelliklerini sunmayı amaçladık.
Anahtar kelimeler: Pediatrik, Periferik primitif nöroektodermal 
tümör, Orbita
Hacer Bal, Erkin Arıbal
Department of Radiology,  School of Medicine, Marmara University, Istanbul, 
Turkey
Cennet Şahin () 
Radiology Clinic, Tekirdağ State Hospital, Tekirdağ, Turkey
e-mail: cennetsahin@yahoo.com
Submitted/Başvuru: 30.06.2013          Accepted/Kabul: 14.08.2013
Table I. The sarcomas relevant to  the differential diagnosis of primary 
pPNET
pPNET HIC-2 gene (+), NSE (+), synaptophysin (+), 
glial fibrillary acidic protein (GFAP) (+), 
MIC2 gene (+)
Ewing’s Sarcoma PGP9.5 antibody (+), MIC2 gene (+)
Rhabdomyosarcoma Actin (+), Vimentin (+), Desmin (+), S-100 (-)
Lymphoma LCA (+),CD45 (+),CD20 (+),CD3 (+)
Neuroblastoma PGP9.5 antibody (+), MIC2 gene (-)
Osteogenic Sarcoma Osteoid (+)
pPNET: Peripheral primitive neuroectodermal tumour
Case Report
An 8-year-old boy was brought to our hospital with 
complaints of progressive protrusion of the left eye ball for 
two months and visual lost for one week. On external ocular 
examination there was a localized, tender, firm, fixed, non-
pulsating globular mass in the superolateral orbit. There was 
an inferior and medial deviation of the left eye, restriction 
of ocular movements superolaterally and total visual loss. 
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He had minimal ptosis and he had no ocular pain. There 
was no history of injury, fever, chronic cough or other 
systemic symptoms. The patient had magnetic resonance 
imaging (MRI) and computed tomography (CT) with a 
prediagnosis of an ocular mass. On non-contrasted cranial 
CT images there was a 36x20 mm space-occupying lesion 
in the left lateral orbital region, causing inferomedial and 
anterior deviation of the left eye (Figure 1). Also there were 
calcifications on posterolateral wall of the eye. On contrast 
enhanced  cranial MRIs, an extention of the lesion along the 
left optic nerve, optic chiasm and optic tract was seen clearly 
(Figure 2). There was also a persistent primary hyperplastic 
vitrea on the left eye.  A neoplastic process was suggested. 
Extensive systemic investigations were done subsequently to 
rule out any other foci of tumour; these included a complete 
hemogram, CT of thorax-abdomen-pelvis, spinal MRI and 
bone marrow biopsy. These were all normal and therefore 
a diagnosis of a primary orbital malignancy was made. The 
patient had a left craniotomy, excision of the orbital rim 
and the mass, a duroplasty  three days after the diagnosis. 
Histopathologic examination of the tumour revealed a diffuse 
collection of small malignant round to oval cells with high 
mitotic activity. Immunohistochemically, the majority of the 
tumour cells were positive for CD99 (MIC2 gene), neuron 
specific enolase (NSE) and the synaptophysin gene. Periodic 
acid-Schiff (PAS) reaction which rules out Ewing’s sarcoma 
was negative. Based on the above findings the patient was 
diagnosed as having  pPNET of the left orbit. Cytogenetic 
studies showed the characteristic t(11;22) chromosomal 
translocation that confirmed the pPNET diagnosis. Following 
the operation, the patient had chemotherapy and radiotherapy 
treatments. Cranial CT and MRI were performed during 
postoperative 24 hours (Figure 3), and control images were 
obtained two months later,  showing no recurrence  and a 
total resection of the mass (Figure 4). 
Discussion
PNET cells are derived from neuroectoderm which appears 
primitive. There are  two types based on the tumour 
location: (1) PNETs in the  CNS; (2) pPNETs outside the 
nervous system [1-3]. Primary orbital location which is a type 
of pPNET, as we present in our case, is extremely rare[1,3]. 
pPNET occurs predominantly in children and young 
adults and show  no gender difference [1,6,7]. Imaging 
and histopathology, though supportive, do not confirm the 
diagnosis. Immunohistochemical and cytogenetic studies 
help in the confirmation of diagnosis. Microscopically, 
primary pPNETs are cellular tumours with small round 
cells that have hyperchromatic nuclei, and a high nuclear–
cytoplasmic ratio. pPNETs differ in their degree of 
neuroectodermal differentiation. They are classified 
under Ewing’s family of tumours (extraosseous type), 
with which they share histopathological and cytogenetic 
similarity [1,3,8]. Immunohistochemical and cytogenetic 
Figure 4. Control contrast-enhanced cranial MRIs, two months after the 
treatment. On axial and sagittal T1-W images there was no recurrence.
Figure 1. On preoperative non-contrast enhanced cranial CT images; the left 
eye is hyperdense compared to the right. There is a 36x20 mm mass in the 
left lateral orbital region, causing inferomedial and anterior deviation of the 
left eye. Also there are calcifications on posterolateral wall of the eye. No 
bone invasion is seen.
Figure 2. Preoperative contrast enhanced T1-W axial (a, b, c) images. 
There is a mass in 36x20 mm diameter that shows marked homogeneous 
enhancement  on the left lateral orbital region, causing inferomedial and 
anterior deviation of the left eye. Extension of the lesion along the  left optic 
nerve, optic chiasm and optic tract is seen clearly. Also a persistent primary 
hyperplastic vitrea is seen on the left eye.
Figure 3. On postoperative same day control non-contrast enhanced cranial 
CT (a, b) and contrast enhanced axial T1-W MR (c) images; there are 
postoperative  (left craniotomy, mass excision, duroplasty) changes on the 
left frontotemporal bone and left frontal lobe after the resection of the  mass. 
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studies suggest that these tumours have a common origin. 
pPNETs occur in soft tissues of the body, resembling soft 
tissue sarcomas (small, round blue-cell tumours) but have 
the same  chromosome translocation as soft tissue Ewing’s 
sarcoma. PNETs and Ewing’s sarcomas commonly have a 
t (11; 22) (q24; q12) translocation [9]. In PNET, there are 
varying degrees of neuronal differentiation, beginning with 
the expression of the neuron-specific enolase (NSE), 
followed by Homer-Wright rosette formation, phenotypic 
ganglion cell differentiation, and finally by the expression 
of neurofilament protein. The presence of Homer-Wright 
rosettes is associated with these tumours but it is not 
diagnostic for these tumours [6]. Ewing’s sarcoma family 
includes Ewing’s sarcoma, pPNET, neuroepithelioma, 
atypical Ewing’s sarcoma and Askin’s tumour (tumour 
of the chest wall). pPNETs are commonly present in the 
thoracopulmonary region (Askin’s tumour), abdomen, pelvis 
or  the extremities [1, 3]. In PNET, immnunohistochemical 
studies can be positive for one or several neural or glial 
markers:  synaptophysin, CD99 (MIC2 gene), glial fibrillary 
acid protein, neurofilaments, chromogranin, S100 protein, 
CD57 (LEU-7/HNK-1), and vimentin. Expression of the 
MIC2 gene produces a glycoprotein antigen MIC2 (CD99), 
which consistently identifies pPNETs/Ewing’s sarcoma. 
These sarcomas typically co-express CD99 (MIC2) and 
vimentin, but central nervous system PNETs (that is, not 
meningeal PNETs) lack the expression of CD99. Positive 
staining for the cited neural markers is very suggestive of 
pPNETs, but it is important to consider the lack of specificity 
of most neural markers and the variable immunohistochemical 
features of pPNET. Ultrastructural studies show the 
presence of neurosecretory granules, cytoplasmic filaments, 
cytoplasmic microtubules and synaptic-like junctions. 
Electron microscopy is a very useful technique but it is not 
available in many centers [3, 4,6,9-11]. CD99 (MIC2 gene), 
NSE and synaptophysin were positive in our case, and this 
confirmed the diagnosis of pPNET. PAS reaction rules out 
Ewing’s sarcoma as in our case. The majority of sarcomas 
that are a part of the differential diagnosis of primary pPNET 
of the orbit are shown in Table I [4,6,11].
pPNETs that occur  in the head and neck region are 
uncommon in most published case series [7, 11]. The 
incidence of pPNETs is likely to be underreported in 
the literature. However, Romero [11] reported 16 cases, 
Hemalatha et al. [5] reported 17 cases with orbital pPNET. 
According to Hemalatha’s study,  only 18 cases have been 
reported in the literature.
Orbital pPNETs tend to occur in younger patients when 
compared with other pPNETs. Only 3 of the 18 published cases 
were older than 13 years at the time of diagnosis [3,5,11]. The 
clinical features of pPNETs depend on the site of presentation 
and mass effect. pPNETs are highly aggressive, and metastasis 
may be the first presentation. The most common sites of pPNET 
metastasis include the lung, bone and bone marrow [5,11-13]. 
The lack of metastasis in the orbital form of pPNET could 
be explained by the poor lymphatic system of the orbit [11].
The treatment for pPNET usually involves a 
combination of surgery and chemotherapy with or without 
radiotherapy [3,6,11]. The modality of treatment depends 
on the type, site and size of tumour, extent of metastasis 
as well as the age and general health status of the patient. 
Surgery has been the initial treatment for orbital pPNET 
in most cases and has been the initial therapeutic approach 
used in our patient, althoug some of the published cases have 
been treated with chemoteraphy and radiotherapy without 
surgery, with  good results [6].  Our case was managed with 
successful resection of the mass, chemotherapy and external 
beam radiotherapy. There was no recurrence on the control 
investigation performed two months after the operation. 
Conclusion
When a primary hypercellular small round cell tumour 
of the orbit is encountered, the recently recognized rare 
pPNET of the orbit should be considered in the differential 
diagnosis although the orbit is an extremely rare site for 
such a tumour. Accurate diagnosis of these tumours is of 
paramount importance.   Immunocytology helps to confirm 
the diagnosis. Management should be aggressive using 
multimodality treatment approaches given at the appropriate 
time. These patients should be followed up for life to rule out 
recurrence, metastasis and treatment-related malignancies. 
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